HMR1766
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HMR1766, covering 2018-05-17 to 2018-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease [Phase 2]